BIOFLOW-III Sweden Satellite Registry

NCT01667003 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 406

Last updated 2017-09-28

No results posted yet for this study

Summary

This registry is a clinical post-market evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES).

Conditions

Sponsors & Collaborators

  • Biotronik ApS

    lead INDUSTRY

Principal Investigators

  • Ole Froebert, MD · Kardiologiska Kliniken

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-12-31
Completion
2015-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01667003 on ClinicalTrials.gov